GlassScriptPhysician profile
Catherine D Carruthers
NPI 1871618215
$17,154.86
in general payments reported to CMS, 2019-2025
20 companies · $700 in 2025
The $700 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,100 · 2021: $134 · 2022: $633 · 2023: $468 · 2024: $1,683 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097 · Travel and Lodging: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.25 |
| Travel and Lodging | $754.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $13,519.95 | 2019-2020 | |
| Elucent Medical | $1,548.96 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $460.74 | 2021-2025 | Enhertu, Imfinzi |
| Daiichi Sankyo INC. | $292.82 | 2022-2025 | Enhertu |
| Kub Technologies INC. | $221.82 | 2022 | |
| Endomagnetics LTD | $182.06 | 2024 | Magtrace, Magseed |
| Stryker Corporation | $173.49 | 2025 | Spy-Phi System |
| Dilon Technologies, INC. | $154.04 | 2023 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $153.90 | 2022-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Lilly USA, LLC | $137.49 | 2024-2025 | Verzenio, Jaypirca |
| Hologic Sales and Service, LLC | $72.92 | 2023 | Localizer, Trunode, Biozorb |
| Eisai INC. | $51.49 | 2023-2025 | |
| Aveo Pharmaceuticals, INC. | $33.60 | 2025 | |
| Novartis Pharmaceuticals Corporation | $30.33 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.55 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $22.76 | 2025 | Trodelvy |
| Myriad Genetic Laboratories, INC. | $21.98 | 2024 | Myrisk |
| Seagen INC. | $18.80 | 2022 | |
| Cardinal Health 414 LLC | $16.25 | 2019 | |
| Solventum Corporation | $15.91 | 2025 | Prevena, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Carruthers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.